跳至主要内容
临床试验/NCT02247427
NCT02247427已完成2 期

Midterm Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders

Yuksek Ihtisas Hospital0 个研究点目标入组 19 人开始时间: 2009年1月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
19
主要终点
Clinical/Echocardiographic outcome

研究概览

简要总结

The purpose of this study is to determine clinical outcomes related to deactivation of Cardiac Resynchronization Therapy device in subjects with super response.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Single (Participant)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •super response to Cardiac Resynchronization Therapy
  • •near normal Left ventricular ejection fraction
  • •>99% pacing

排除标准

  • •<99% pacing
  • •atrial fibrillation
  • •ischemic cardiomyopathy

研究组 & 干预措施

Off-pace group

Experimental

Deactivated device group

干预措施: Cardiac Resynchronization Therapy Device (Device)

On-Pace group

No Intervention

Ongoing device activity group

结局指标

主要结局

Clinical/Echocardiographic outcome

时间窗: 12 months

Clinical/Echocardiographic outcome including New York Heart Association class, 6-min walk test, Left ventricular ejection fraction, Left ventricular end- diastolic diameter, Left ventricular end-systolic volume, and Left ventricular end-systolic diameter.

次要结局

  • Mortality(12 months)
  • Heart failure hospitalization(12 months)
  • Cardiac Resynchronization Therapy Device intervention(12 months)

研究者

发起方
Yuksek Ihtisas Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Serkan Cay

Associate Professor

Yuksek Ihtisas Hospital

相似试验

Clinical Outcomes Related to Cardiac... | 临床试验